A detailed history of Napatree Capital LLC transactions in Organon & Co. stock. As of the latest transaction made, Napatree Capital LLC holds 28,515 shares of OGN stock, worth $214,717. This represents 0.24% of its overall portfolio holdings.

Number of Shares
28,515
Previous 29,854 4.49%
Holding current value
$214,717
Previous $445 Million 4.68%
% of portfolio
0.24%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025

SELL
$14.29 - $16.41 $19,134 - $21,972
-1,339 Reduced 4.49%
28,515 $425 Million
Q4 2024

Feb 11, 2025

BUY
$14.44 - $18.83 $431,091 - $562,150
29,854 New
29,854 $445 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.